Guaifenesin D
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0536-1333 -
Package NDC
0536-1333-21 -
Package NDC
0536-1333-36 -
Application number
ANDA212542 -
SPL ID
5123ee03-a227-4e51-e063-6294a90ab1a0 -
SPL set ID
997946e6-eff0-4c15-8694-020a19c2d336 -
UNII
495W7451VQ -
UNII
6V9V2RYJ8N -
RxCUI
1305603
What the source publishes
- Labeler
- RUGBY LABORATORIES, INC.
- Active ingredients
- Guaifenesin and Pseudoephedrine Hydrochloride
- Form
- TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN OTC DRUG
- Prescription
- Non-prescription
Names this record is found by
- Guaifenesin D
- Guaifenesin and Pseudoephedrine Hydrochloride
- GUAIFENESIN
- PSEUDOEPHEDRINE HYDROCHLORIDE
Complete source data
{
"name": "Guaifenesin D",
"splId": "5123ee03-a227-4e51-e063-6294a90ab1a0",
"labels": [
{
"setId": "997946e6-eff0-4c15-8694-020a19c2d336",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=997946e6-eff0-4c15-8694-020a19c2d336",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=997946e6-eff0-4c15-8694-020a19c2d336"
}
],
"routes": [
"ORAL"
],
"labeler": "RUGBY LABORATORIES, INC.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 BLISTER PACK in 1 CARTON (0536-1333-21) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK",
"package_ndc": "0536-1333-21",
"identifierStatus": "well-formed",
"marketing_end_date": "20270331",
"marketing_start_date": "20220404"
},
{
"sample": false,
"description": "2 BLISTER PACK in 1 CARTON (0536-1333-36) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK",
"package_ndc": "0536-1333-36",
"identifierStatus": "well-formed",
"marketing_end_date": "20270331",
"marketing_start_date": "20220404"
}
],
"productId": "0536-1333_5123ee03-a227-4e51-e063-6294a90ab1a0",
"useDomain": "unknown",
"dosageForm": "TABLET, EXTENDED RELEASE",
"productNdc": "0536-1333",
"deaSchedule": null,
"genericName": "Guaifenesin and Pseudoephedrine Hydrochloride",
"productType": "HUMAN OTC DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": "20270331",
"activeIngredients": [
{
"name": "GUAIFENESIN",
"strength": "600 mg/1"
},
{
"name": "PSEUDOEPHEDRINE HYDROCHLORIDE",
"strength": "60 mg/1"
}
],
"applicationNumber": "ANDA212542",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20220404",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "non-prescription",
"harmonizedIdentifiers": {
"nui": [
"N0000193956",
"N0000008867",
"N0000009560"
],
"unii": [
"495W7451VQ",
"6V9V2RYJ8N"
],
"rxcui": [
"1305603"
],
"spl_set_id": [
"997946e6-eff0-4c15-8694-020a19c2d336"
],
"pharm_class_pe": [
"Decreased Respiratory Secretion Viscosity [PE]",
"Increased Respiratory Secretions [PE]"
],
"pharm_class_epc": [
"Expectorant [EPC]"
],
"manufacturer_name": [
"RUGBY LABORATORIES, INC."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": null
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0536-1333_5123ee03-a227-4e51-e063-6294a90ab1a0"